Mini-Review
A novel gross deletion in SMARCAL1 impairs DNA replication fork regression, leading to severe Schimke immuno-osseous dysplasia; a literature review and an integrated study of clinical, genetic, and protein-protein interaction analysis
Mohammad Saberi
1 
, Morteza Talebi
2 
, Ali Ghorbani
3 
, Azadeh Reshadmanesh
4 
, Samin Sharafian
5 
, Zahra Chavoshzadeh
6 
, Masumeh Mohkam
7 
, Arefeh Zahmatkesh
8 
, Paniz Pourpashang
8,9*
1 Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
3 Protein Research Center, Shahid Beheshti University, Tehran, Iran
4 Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
5 Department of Immunology and Allergy, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Pediatric Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
8 Pediatric Chronic Kidney Disease Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran
9 Department of Pediatric Nephrology, Bahrami Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Paniz Pourpashang, Email: p-pourpashang@sina.tums.ac.ir, Email:
paaniz.p@gmail.com
Abstract
Schimke immuno-osseous dysplasia (SIOD) is an exceptionally rare autosomal recessive disorder that affects multiple organ systems, most notably the skeletal system, kidneys, and immune system. The clinical manifestations of SIOD include growth retardation, skeletal deformities, progressive proteinuria, and immunodeficiency. Severe cases may progress to nephrotic syndrome and cerebral infarctions. The disorder is primarily attributed to biallelic mutations in the SMARCAL1 gene, which leads to the early onset of symptoms and often results in premature mortality. In this study, we identified a novel gross deletion encompassing exons 5 and 6 of the SMARCAL1 gene. This deletion leads to a partial loss of the HARP1 and HARP2 domains and the generation of a novel HARP domain that is structurally similar to both HARP1 and HARP2, while retaining conserved amino acids. Our AlphaFold 3D modeling indicated that the truncated SMARCAL1 protein is identical to the wild-type SMARCAL1, except for the absence of HARP1 domain, and resembles invertebrate SMARCAL1, which naturally possesses only one HARP domain. Previous studies have demonstrated that human SMARCAL1 lacking the HARP1 domain retains normal helicase, ATPase, and DNA-binding activities. Additionally, invertebrate SMARCAL1, which also lacks the HARP1 domain, fails to effectively regress DNA replication forks. This suggests that the identified gross deletion may contribute to SIOD pathogenesis by impairing DNA replication fork regression and genomic instability.
Citation: Saberi M, Talebi M, Ghorbani A, Reshadmanesh A, Sharafian S, Chavoshzadeh Z, Mohkam M, Zahmatkesh A, Pourpashang P. A novel gross deletion in SMARCAL1 impairs DNA replication fork regression, leading to severe Schimke immunoosseous dysplasia; a literature review and an integrated study of clinical, genetic, and protein-protein interaction analysis. Immunopathol Persa. 2025;x(x):e43980. DOI:10.34172/ipp.2025.43980.